Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK7/9-IN-1 is a specific inhibitor of cyclin-dependent kinases 7/9 (CDK7/9), targeting CDK7 with IC50 values of 0.0656 μM without pre-incubation and 0.00574 μM after 3 hours pre-incubation, and displaying inhibitory activity against CDK9 with an IC50 of 2.14 μM after 3 hours pre-incubation, making it valuable for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | CDK7/9-IN-1 is a specific inhibitor of cyclin-dependent kinases 7/9 (CDK7/9), targeting CDK7 with IC50 values of 0.0656 μM without pre-incubation and 0.00574 μM after 3 hours pre-incubation, and displaying inhibitory activity against CDK9 with an IC50 of 2.14 μM after 3 hours pre-incubation, making it valuable for cancer research. |
Targets&IC50 | CDK9:2.14 μM (IC50), CDK7:5.74-65.6 nM (IC50) |
In vitro | CDK7/9-IN-1 (example 8; 0.001-20 μM; 4 h) selectively inhibits CDK7, CDK9, and cMyc in HCT116 cells, with IC50 values of 0.0262 μM, 2.59 μM, and 0.0138 μM, respectively, for their targeted phospho-carboxyl terminal domains (Rbp2) (Ser5 for CDK7 and Ser2 for CDK9). At concentrations of 20 μM, 2 μM, and 0.2 μM for 1 hour, CDK7/9-IN-1 exhibits exceptional selectivity, inhibiting approximately 96% of CDK7 activity across a panel of 468 protein kinases[1]. |
Alias | CDK7/9-IN-1 |
Molecular Weight | 479.548 |
Formula | C24H32F3N5O2 |
Cas No. | 2747919-19-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.